Senores Pharmaceuticals Ltd.

•

₹ 1,513.30%

2026-08-21

senorespharma.comBSE: 544319NSE: SENORES

Market Cap₹ 7,151 Cr.

Current Price₹ 1,513

High / Low₹ 1,578 / 662

Stock P/E56.6

Book Value₹ 209

Price to Book3.35

Dividend Yield0.00 %

ROCE11.9 %

ROE11.8 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

Latest quarter profit grew 43.8% YoY, showing strong momentum
Operating margins have improved to 22.5% from 17.0%
Institutional investors have been accumulating - FII+DII up 3.2pp
Company maintains a comfortable, low leverage position

CONS

Operating cash flow has been negative in recent years
A large part of profit comes from other income (27.4% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.73x)
Working capital days have increased from 6 to 442 days
Equity base is being diluted - shares outstanding up 426.8%
Free cash flow has been persistently negative

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %	OPM %
1.	SUNPHARMA	1898.00	37.65	455393.78	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	8525.00	77.37	226311.96	0.35	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5013.00	87.43	190678.41	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1416.00	33.94	114392.01	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1105.00	24.42	110224.17	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LUPIN	2220.00	18.36	101506.15	0.81	1416.98	16.01	8276.89	34.28	28.86	29.59
7.	MANKIND	2391.00	48.34	98747.34	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
8.	DRREDDY	1171.00	30.33	97740.54	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LAURUSLABS	1807.00	89.30	97634.42	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
10.	AUROPHARMA	1615.15	25.03	92932.16	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	BIOCON	414.30	136.32	67518.23	0.12	136.80	53.36	4336.00	10.89	3.26	19.54
12.	SENORES	1552.80	56.59	7151.20	0.00	30.45	43.77	180.21	38.30	11.94	29.83

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	79	102	80	98	103	114	130	153	165	175	180
	64	80	59	77	77	95	104	112	121	128	144
Operating Profit	—	—	—	—	—	—	—	—	—	—	—
OPM %	—	—	—	—	—	—	—	—	—	—	—
Other Income	1	2	0	2	5	12	3	5	4	18	3
Interest	2	3	5	5	6	5	5	6	5	8	7
Depreciation	3	4	4	4	4	5	6	8	8	9	10
	10	18	13	16	20	21	26	41	45	47	39
Tax %	30.63%	19.48%	18.95%	18.24%	19.82%	13.10%	20.05%	25.89%	24.69%	22.64%	22.83%
Net Profit	0	0	0	0	16	18	21	30	34	37	30
	4	8	3	4	5	4	5	7	7	8	1
Equity Capital	30	31	33	33	46	46	46	46	46	46	46
Reserves	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Equity Capital	30	31	33	33	46	46	46	46	46	46	46
Reserves	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dec 2023

: 79
: 64
Operating Profit: —
OPM %: —
Other Income: 1
Interest: 2
Depreciation: 3
: 10
Tax %: 30.63%
Net Profit: 0
: 4
Equity Capital: 30
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 30
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2024

: 102
: 80
Operating Profit: —
OPM %: —
Other Income: 2
Interest: 3
Depreciation: 4
: 18
Tax %: 19.48%
Net Profit: 0
: 8
Equity Capital: 31
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 31
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2024

: 80
: 59
Operating Profit: —
OPM %: —
Other Income: 0
Interest: 5
Depreciation: 4
: 13
Tax %: 18.95%
Net Profit: 0
: 3
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%

Sep 2024

: 98
: 77
Operating Profit: —
OPM %: —
Other Income: 2
Interest: 5
Depreciation: 4
: 16
Tax %: 18.24%
Net Profit: 0
: 4
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 33
Reserves: 0
Promoter Pledge %: 0.00%

Dec 2024

: 103
: 77
Operating Profit: —
OPM %: —
Other Income: 5
Interest: 6
Depreciation: 4
: 20
Tax %: 19.82%
Net Profit: 16
: 5
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2025

: 114
: 95
Operating Profit: —
OPM %: —
Other Income: 12
Interest: 5
Depreciation: 5
: 21
Tax %: 13.10%
Net Profit: 18
: 4
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2025

: 130
: 104
Operating Profit: —
OPM %: —
Other Income: 3
Interest: 5
Depreciation: 6
: 26
Tax %: 20.05%
Net Profit: 21
: 5
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Sep 2025

: 153
: 112
Operating Profit: —
OPM %: —
Other Income: 5
Interest: 6
Depreciation: 8
: 41
Tax %: 25.89%
Net Profit: 30
: 7
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Dec 2025

: 165
: 121
Operating Profit: —
OPM %: —
Other Income: 4
Interest: 5
Depreciation: 8
: 45
Tax %: 24.69%
Net Profit: 34
: 7
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Mar 2026

: 175
: 128
Operating Profit: —
OPM %: —
Other Income: 18
Interest: 8
Depreciation: 9
: 47
Tax %: 22.64%
Net Profit: 37
: 8
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Jun 2026

: 180
: 144
Operating Profit: —
OPM %: —
Other Income: 3
Interest: 7
Depreciation: 10
: 39
Tax %: 22.83%
Net Profit: 30
: 1
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%
Equity Capital: 46
Reserves: 0
Promoter Pledge %: 0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	14	35	215	398	674
	12	23	173	309	504
Operating Profit	2	16	44	109	—
OPM %	17	46	21	27	—
Other Income	0	4	3	19	30
Interest	1	2	9	22	27
Depreciation	1	2	10	17	35
	1	12	25	71	172
Tax %	13	32	-31	17	24
Net Profit	1	8	33	58	131
EPS	2	7	10	13	—
Dividend Payout %	0	0	0	0	—
Minority Interest	0	0	-1	0	-2
Share of Associates	0	0	0	0	0
Adjusted EPS	1	9	10	13	—
Minority Interest	0	0	-1	0	-2
Share of Associates	0	0	0	0	0
Adjusted EPS	1	9	10	13	—

Mar 2022

: 14
: 12
Operating Profit: 2
OPM %: 17
Other Income: 0
Interest: 1
Depreciation: 1
: 1
Tax %: 13
Net Profit: 1
EPS: 2
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 1

Mar 2023

: 35
: 23
Operating Profit: 16
OPM %: 46
Other Income: 4
Interest: 2
Depreciation: 2
: 12
Tax %: 32
Net Profit: 8
EPS: 7
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 9
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 9

Mar 2024

: 215
: 173
Operating Profit: 44
OPM %: 21
Other Income: 3
Interest: 9
Depreciation: 10
: 25
Tax %: -31
Net Profit: 33
EPS: 10
Dividend Payout %: 0
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: 10
Minority Interest: -1
Share of Associates: 0
Adjusted EPS: 10

Mar 2025

: 398
: 309
Operating Profit: 109
OPM %: 27
Other Income: 19
Interest: 22
Depreciation: 17
: 71
Tax %: 17
Net Profit: 58
EPS: 13
Dividend Payout %: 0
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 13
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 13

TTM

: 674
: 504
Operating Profit: —
OPM %: —
Other Income: 30
Interest: 27
Depreciation: 35
: 172
Tax %: 24
Net Profit: 131
EPS: —
Dividend Payout %: —
Minority Interest: -2
Share of Associates: 0
Adjusted EPS: —
Minority Interest: -2
Share of Associates: 0
Adjusted EPS: —

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 204%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 290%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 113%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 20%
Last Year:: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-
Equity Capital	9	10	31	46
	28	36	174	740
	2	28	97	31
Trade Payables	7	14	113	67
	13	44	193	324
Total Liabilities	59	131	607	1,208
ASSETS	-	-	-	-
	7	27	235	301
Capital Work in Progress	0	8	18	44
	15	16	0	0
	3	3	37	57
	0	0	112	124
Cash & Bank	3	0	13	386
	30	76	191	297
Total Assets	59	131	607	1,208
Total Debt	14	61	248	305
Net Working Capital	17	-1	3	482
Contingent Liabilities	0	8	23	21
Book Value per Share	41.86	46.36	66.95	170.72
Face Value	10.00	10.00	10.00	10.00
Total Debt	14	61	248	305
Net Working Capital	17	-1	3	482
Contingent Liabilities	0	8	23	21
Book Value per Share	41.86	46.36	66.95	170.72
Face Value	10.00	10.00	10.00	10.00

Mar 2022

Equity Capital: 9
: 28
: 2
Trade Payables: 7
: 13
Total Liabilities: 59
: 7
Capital Work in Progress: 0
: 15
: 3
: 0
Cash & Bank: 3
: 30
Total Assets: 59
Total Debt: 14
Net Working Capital: 17
Contingent Liabilities: 0
Book Value per Share: 41.86
Face Value: 10.00
Total Debt: 14
Net Working Capital: 17
Contingent Liabilities: 0
Book Value per Share: 41.86
Face Value: 10.00

Mar 2023

Equity Capital: 10
: 36
: 28
Trade Payables: 14
: 44
Total Liabilities: 131
: 27
Capital Work in Progress: 8
: 16
: 3
: 0
Cash & Bank: 0
: 76
Total Assets: 131
Total Debt: 61
Net Working Capital: -1
Contingent Liabilities: 8
Book Value per Share: 46.36
Face Value: 10.00
Total Debt: 61
Net Working Capital: -1
Contingent Liabilities: 8
Book Value per Share: 46.36
Face Value: 10.00

Mar 2024

Equity Capital: 31
: 174
: 97
Trade Payables: 113
: 193
Total Liabilities: 607
: 235
Capital Work in Progress: 18
: 0
: 37
: 112
Cash & Bank: 13
: 191
Total Assets: 607
Total Debt: 248
Net Working Capital: 3
Contingent Liabilities: 23
Book Value per Share: 66.95
Face Value: 10.00
Total Debt: 248
Net Working Capital: 3
Contingent Liabilities: 23
Book Value per Share: 66.95
Face Value: 10.00

Mar 2025

Equity Capital: 46
: 740
: 31
Trade Payables: 67
: 324
Total Liabilities: 1,208
: 301
Capital Work in Progress: 44
: 0
: 57
: 124
Cash & Bank: 386
: 297
Total Assets: 1,208
Total Debt: 305
Net Working Capital: 482
Contingent Liabilities: 21
Book Value per Share: 170.72
Face Value: 10.00
Total Debt: 305
Net Working Capital: 482
Contingent Liabilities: 21
Book Value per Share: 170.72
Face Value: 10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-10	-1	-26	-46
Cash from Investing	-24	-48	-54	-429
Cash from Financing	36	46	87	573
	2	-3	7	98
Free Cash Flow	-10	-31	-254	-154
OCF / Net Profit	-10.54	-0.13	-0.79	-0.79
Cumulative 5-Year FCF	0	0	0	0
OCF / Net Profit	-10.54	-0.13	-0.79	-0.79
Cumulative 5-Year FCF	0	0	0	0

Mar 2022

: -10
Cash from Investing: -24
Cash from Financing: 36
: 2
Free Cash Flow: -10
OCF / Net Profit: -10.54
Cumulative 5-Year FCF: 0
OCF / Net Profit: -10.54
Cumulative 5-Year FCF: 0

Mar 2023

: -1
Cash from Investing: -48
Cash from Financing: 46
: -3
Free Cash Flow: -31
OCF / Net Profit: -0.13
Cumulative 5-Year FCF: 0
OCF / Net Profit: -0.13
Cumulative 5-Year FCF: 0

Mar 2024

: -26
Cash from Investing: -54
Cash from Financing: 87
: 7
Free Cash Flow: -254
OCF / Net Profit: -0.79
Cumulative 5-Year FCF: 0
OCF / Net Profit: -0.79
Cumulative 5-Year FCF: 0

Mar 2025

: -46
Cash from Investing: -429
Cash from Financing: 573
: 98
Free Cash Flow: -154
OCF / Net Profit: -0.79
Cumulative 5-Year FCF: 0
OCF / Net Profit: -0.79
Cumulative 5-Year FCF: 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE	-	-	-	-
EPS (₹)	1.13	8.59	10.31	12.72
Book Value (₹)	41.86	46.36	66.95	170.72
Dividend per Share (₹)	0.00	0.00	0.00	0.00
Cash EPS (₹)	1.94	10.40	14.00	16.33
PROFITABILITY	-	-	-	-
Operating Margin %	17.03%	46.28%	19.38%	22.51%
Net Margin %	6.99%	23.86%	15.25%	14.65%
ROE %	2.71%	20.55%	26.19%	11.78%
ROCE %	3.36%	18.56%	12.31%	11.94%
	1.69%	8.89%	8.86%	6.43%
EFFICIENCY	-	-	-	-
Debtor Days	506	216	114	108
Inventory Days	77	32	34	43
Payable Days	324	296	218	182
	258	-49	-69	-31
FINANCIAL HEALTH	-	-	-	-
Debt to Equity (x)	0.39x	1.34x	1.22x	0.39x
Interest Coverage (x)	3.02x	6.82x	3.64x	4.27x
	2.74x	0.99x	1.01x	3.00x
GROWTH	-	-	-	-
Revenue Growth %	0.00%	149.38%	507.07%	85.65%
Operating Profit Growth %	0.00%	577.75%	171.43%	145.46%
Net Profit Growth %	0.00%	750.96%	287.88%	78.36%
	0.00%	0.00%	20.01%	23.33%
VALUATION	-	-	-	-
P/E (x)	0.00x	0.00x	0.00x	45.04x
P/B (x)	0.00x	0.00x	0.00x	3.35x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	5.99x	23.47x

Mar 2022

EPS (₹): 1.13
Book Value (₹): 41.86
Dividend per Share (₹): 0.00
Cash EPS (₹): 1.94
Operating Margin %: 17.03%
Net Margin %: 6.99%
ROE %: 2.71%
ROCE %: 3.36%
: 1.69%
Debtor Days: 506
Inventory Days: 77
Payable Days: 324
: 258
Debt to Equity (x): 0.39x
Interest Coverage (x): 3.02x
: 2.74x
Revenue Growth %: 0.00%
Operating Profit Growth %: 0.00%
Net Profit Growth %: 0.00%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2023

EPS (₹): 8.59
Book Value (₹): 46.36
Dividend per Share (₹): 0.00
Cash EPS (₹): 10.40
Operating Margin %: 46.28%
Net Margin %: 23.86%
ROE %: 20.55%
ROCE %: 18.56%
: 8.89%
Debtor Days: 216
Inventory Days: 32
Payable Days: 296
: -49
Debt to Equity (x): 1.34x
Interest Coverage (x): 6.82x
: 0.99x
Revenue Growth %: 149.38%
Operating Profit Growth %: 577.75%
Net Profit Growth %: 750.96%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2024

EPS (₹): 10.31
Book Value (₹): 66.95
Dividend per Share (₹): 0.00
Cash EPS (₹): 14.00
Operating Margin %: 19.38%
Net Margin %: 15.25%
ROE %: 26.19%
ROCE %: 12.31%
: 8.86%
Debtor Days: 114
Inventory Days: 34
Payable Days: 218
: -69
Debt to Equity (x): 1.22x
Interest Coverage (x): 3.64x
: 1.01x
Revenue Growth %: 507.07%
Operating Profit Growth %: 171.43%
Net Profit Growth %: 287.88%
: 20.01%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 5.99x

Mar 2025

EPS (₹): 12.72
Book Value (₹): 170.72
Dividend per Share (₹): 0.00
Cash EPS (₹): 16.33
Operating Margin %: 22.51%
Net Margin %: 14.65%
ROE %: 11.78%
ROCE %: 11.94%
: 6.43%
Debtor Days: 108
Inventory Days: 43
Payable Days: 182
: -31
Debt to Equity (x): 0.39x
Interest Coverage (x): 4.27x
: 3.00x
Revenue Growth %: 85.65%
Operating Profit Growth %: 145.46%
Net Profit Growth %: 78.36%
: 23.33%
P/E (x): 45.04x
P/B (x): 3.35x
Dividend Yield %: 0.00%
: 23.47x

Shareholding Pattern

Numbers in percentages

TRADES

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	45.76	45.76	45.77	45.78	45.80	45.80	45.82	45.82
	5.52	4.24	4.17	3.66	4.28	3.35	3.64	6.62
	16.61	11.49	9.66	9.51	8.62	9.32	9.62	9.77
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.11	38.48	40.40	41.04	41.31	41.54	40.93	37.79

Sep 2024

: 45.76
: 5.52
: 16.61
Government: 0.00
: 32.11

Dec 2024

: 45.76
: 4.24
: 11.49
Government: 0.00
: 38.48

Mar 2025

: 45.77
: 4.17
: 9.66
Government: 0.00
: 40.40

Jun 2025

: 45.78
: 3.66
: 9.51
Government: 0.00
: 41.04

Sep 2025

: 45.80
: 4.28
: 8.62
Government: 0.00
: 41.31

Dec 2025

: 45.80
: 3.35
: 9.32
Government: 0.00
: 41.54

Mar 2026

: 45.82
: 3.64
: 9.62
Government: 0.00
: 40.93

Jun 2026

: 45.82
: 6.62
: 9.77
Government: 0.00
: 37.79

Documents

Announcements

Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-20 - Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet
Shareholders meeting
2026-08-04 - Senores Pharmaceuticals Limited has submitted the Exchange regarding Outcome of Postal Ballot and Scutinizer Report dated August 04, 2026

Annual Reports

Nothing filed yet.

Credit Ratings

Nothing filed yet.

Concalls

Aug 2026
Transcript PPTREC
May 2026
Transcript PPTREC
Jan 2026
Transcript PPTREC